The Squeeze on Tweed's Cannabis Extracts License
We are pleased to announce to our customers that we have received authorization from Health Canada to begin the production of cannabis extracts.
Tweed will use preeminent pharmaceutical grade extraction methods to produce purified cannabis derivatives.
“Our customers have come to expect the best from Tweed’s product lines,” said Bruce Linton, the Company’s Chairman and CEO. “The major advantage that comes with commercial scale is that you can provide products to customers that they couldn’t make themselves at home.”
We’ve been working hard on developing our new line of cannabis extracts, and as always have focused on having a variety of strain specific products available from the outset.
In addition to this license, we have also received approval on new state of the art drying, trimming, processing, and extraction rooms – ensuring we can maintain quality while we increase production.
We look forward to keeping you up to date as we begin to roll out our newline of extracts, providing our customers with even more products to choose from.
Here’s to future growth.
← Prev Next →
other stories you may be interested in
Crohn’s Patients Share A Common Solution
With one in every 150 people affected, Canada has the highest per capita rate of Crohn’s or ulcerative colitis of any country...
A Rebel Salute to Reggae, Ganja and Reform
Over the past 30 years, there have been few players in Jamaican music that have formed as significant of a cultural footprint as Tony Rebel...
Here’s to Future Growth in the New Year
As we prepare for what promises to be a banner year for Canada’s budding cannabis industry, we’re taking a little time to reflect on some of the milestones we reached in 2016...